SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-062473
Filing Date
2019-03-04
Accepted
2019-03-04 16:30:03
Documents
4
Period of Report
2019-03-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d718027d8k.htm 8-K 31658
2 EX-10.1 d718027dex101.htm EX-10.1 80510
3 EX-10.2 d718027dex102.htm EX-10.2 71033
4 EX-10.3 d718027dex103.htm EX-10.3 48094
  Complete submission text file 0001193125-19-062473.txt   232598
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 19654163
SIC: 2834 Pharmaceutical Preparations